CLINICAL_TRIALS
trial_result
· 2023-09-08
Clinical Trial Update: Effect of DLBS1033 After Primary PCI in Patients With STE-ACS [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial evaluating DLBS1033 after primary PCI in ST-elevation myocardial infarction has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dexa Medica Group | Conditions: ST Elevation Myocardial Infarction | Phase 2, Phase 3 | Status: TERMINATED